Overview

Investors


Company Profile

RTI Surgical Holdings, Inc. is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic-based implants around the world. RTI prepares donated human tissue and animal tissue for transplantation through extensive testing and screening, precision shaping and proprietary, validated sterilization processes, and innovative processes are used to design and manufacture high-quality metal and synthetic-based implants. These products are used in spine, sports medicine, orthopedic, dental and other surgical specialties. Please refer to our latest investor presentation for additional information.

View All Stock Information

Q3

2019 Results

See All

Email Alerts


Name*

Contact

  • Molly Poarch
    Director, Corporate Communications & Investor Relations
    mpoarch@rtix.com
    +1 224 287 2661
  • Jessica Rumschlag
    Executive Assistant, Investor Relations
    jrumschlag@rtix.com
    +1 630 652 5909
  • Transfer Agent
    Kayur Patel | Relationship Manager, BCIS | Broadridge Financial Solutions, Inc.
    2 Gateway Center| 283 -299 Market Street, 15th Floor | Newark, NJ 07102 | USA
    p +1 201 714 3169 | m +1 551 200 3202
    Kayur.Patel@broadridge.com